Novartis AG · NVS · Next earnings

Novartis AG reports Tuesday, Oct 27, 2026

NVS reports before market open with consensus EPS at $2.25 and revenue at $14.53B. Last quarter: Novartis raises profit outlook as priority brands drive Q3 growth

Reports Before market open0 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $2.25 Calendar consensus
Consensus revenue $14.53B Calendar consensus
Report date Oct 27, 2026 Tuesday, date estimated
Session Before market open 0 days away

Where NVS left off: FY2026 Q3

Full report

Novartis raises profit outlook as priority brands drive Q3 growth

EPS surprise — Reported — vs $2.25
Revenue surprise — Reported — vs $14.53B
Stock move +1.2% Event window
Subsequent drift 0.0% Up to 20 sessions

Management raised full-year 2026 core operating income guidance while reaffirming its sales-growth outlook.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Generic erosion affecting Entresto, Tasigna and other legacy products.
  • Xolair biosimilar competition and broader competitive pressure in oncology and immunology.
  • Regulatory delays or safety issues involving inalumab, delgociptacine and Rhapsido.
  • Further failed late-stage readouts could result in additional impairment charges.

Questions analysts left open

  • Whether Q4 sales growth and margin expansion can persist amid seasonal spending.
  • The scale of generic erosion across Entresto and other legacy products.
  • The timing and commercial impact of Xolair biosimilar competition.
  • Regulatory timelines for inalumab, delgociptacine and Rhapsido, plus remibrutinib switching and cannibalisation risk.

Ask FN2 about NVS next report

Transcript, numbers and history already loaded
What should I watch for in NVS's next earnings report?How did NVS guide last quarter, and is consensus above or below that?Give me the bull and bear case going into NVS earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the NVS recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent NVS quarters

All NVS earnings
+1.2%FY2026 Q3+2.9%FY2026 Q2+2.0%FY2025 Q4

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.